Delivery Order SPE2DB24D1104-SPE2DB24FXUD2
Award Date
2/13/24
Potential Completion Date
3/6/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distribution company. The $1,465.68 firm-fixed-price delivery order is for the supply of Envarsus XR 1 mg tablets. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, a firm fixed price delivery order contract worth $1,216.11 for the supply of Envarsus XR 1 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Envarsus XR 1 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order has a potential value of $1,216.11 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this contract, which is not designated as a set-aside. The company holds an indefinite delivery contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Envarsus XR 1 mg tablets, a pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD), with a ceiling value of $1,465.68. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,423.90 Firm Fixed Price Delivery Order contract, which runs through February 2025, is for the supply of Envarsus XR 4 mg tablets. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Envarsus XR 0.75 mg tablets over a period ending on October 9, 2024. The contract has a ceiling value of $1,103.64 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,621.48, is a delivery order for the pharmaceutical product ENVARSUS XR 1 MG TABLET 100S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant Indefinite Delivery Contract (IDC) valued up...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Envarsus XR 4 mg tablets. The $7,713.57 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award, valued at $1,621.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, for the delivery of Envarsus XR 1 mg tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Envarsus XR 1 mg tablet in quantities of 30. The $1,465.68 ceiling value Firm Fixed Price contract was awarded on June 11, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of July 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a...